Back to Search
Start Over
Allergan announces new data from CENTAUR phase 2b study supports continued development of CVC in ongoing phase 3 AURORA trial
- Source :
- PharmaBiz. September 25, 2017
- Publication Year :
- 2017
-
Abstract
- Allergan plc announced top-line results from new data for the CENTAUR phase 2b study which supports the anti-fibrotic efficacy and safety of Cenicriviroc (CVC) for the treatment of liver fibrosis [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.506342722